Joana Goncalves, Chief Medical Officer at Oruka Therapeutics, Inc. (ORKA), sold 14,641 shares at $40.11 ($599K) on 2026-03-16, disclosed to the SEC on 2026-03-17.
Scheduled sale ($599k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.11 | 2,921 | $117K | 19.6% |
| 2 | $40.11 | 2,921 | $117K | 19.6% |
| 3 | $41.20 | 2,902 | $120K | 20.0% |
| 4 | $41.20 | 2,902 | $120K | 20.0% |
| 5 | $41.30 | 641 | $26K | 4.4% |
| 6 | $41.94 | 1,177 |
| $49K |
| 8.2% |
| 7 | $41.94 | 1,177 | $49K | 8.2% |
| Total | $40.89 avg | 14,641 | $599K | 100% |
| Filing → |
| ORKA | SELL | 2026-07-15 | $604K | — | Filing → |
| ORKA | SELL | 2026-06-15 | $551K | — | Filing → |
| ORKA | SELL | 2026-05-15 | $433K | — | Filing → |